Loading...
XHKG
8037
Market cap79mUSD
Jul 10, Last price  
0.61HKD
1D
-4.69%
1Q
-16.44%
Jan 2017
69.44%
IPO
-96.85%
Name

China Biotech Services Holdings Ltd

Chart & Performance

D1W1MN
XHKG:8037 chart
P/E
—
P/S
8.10
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.15%
Rev. gr., 5y
-35.45%
Revenues
74m
+4.25%
243,386,000270,753,000272,277,000160,522,00084,184,00045,017,000101,354,00085,300,000140,385,00034,127,00086,565,000105,135,00070,304,00059,214,000655,792,000623,761,0001,851,532,000211,985,00070,509,00073,503,000
Net income
-69m
L-65.29%
528,000-38,333,000-37,425,000-83,561,000-16,465,000-43,555,000-20,698,000-60,231,200-82,929,000-62,269,000-50,151,000-63,022,000-64,250,000-107,483,00030,170,00019,385,000258,087,000-95,447,000-198,146,000-68,778,000
CFO
-54m
L-64.13%
22,720,000-18,547,000-20,636,0008,362,000-1,508,000-27,020,000-1,574,000-41,720,000-40,011,000-85,123,000-25,392,000-56,951,000-14,759,000-30,306,000421,999,00040,505,000482,748,000191,722,000-151,890,000-54,490,000
Dividend
May 19, 20230.01 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
URL
http://www.cbshhk.com/
IPO date
Jun 17, 2004
Employees
187
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT